The invention relates to aerosol generators or nebulizers, having vibrating aperture plates to aerosolize medicaments.
Examples of nebulizers are described in U.S. Pat. No. 6,546,927 (Litherland) and EP1558315 (PART). These disclosures include techniques to predict the end of a liquid medicament dose on the aperture plate. These techniques are based on monitoring a parameter such as drive current at different drive frequencies.
The approach taught in the Litherland document involves detecting the present desired frequency, and the desired frequency may for example be the resonant frequency. Frequency is the variable that is swept, and a parameter is tracked. The tracking provides an indication of the desired drive frequency. This may change as the dose decreases in volume. For example, the resonant frequency may drift from 135 kHz to 140 kHz from a loaded state to an unloaded state. In Litherland the device can reduce power supplied to the aperture plate and/or provide a user indication as the dose is ending.
The present invention is directed towards providing improved frequency control. Specifically, it is desired to improve any one or all of faster frequency control response to changes in conditions, less impact on the nebulisation process, and improved ability to accurately predict end-of-dose when used with patients who inhale medication at different rates.
According to the invention, there is provided a nebulizer comprising a vibrating aperture plate, a mounting, an actuator, and an aperture plate drive circuit having a controller, wherein the controller is configured to:
In one embodiment, the short scan has fewer than five, and preferably two measuring points (CPt #1. CPt #2).
In one embodiment, the controller is configured to compare measurements with tolerance ranges, and if a measurement falls outside its associated range a full scan is initiated. In one embodiment, the tolerance ranges are pre-defined.
In one embodiment, the short scan is performed at regular intervals. Preferably, the intervals are sub-second.
In one embodiment, the full scan has in the range of 5 to 300 measuring points. In one embodiment, the full scan has in the range of 100 to 300 measuring points.
In one embodiment, the controller is configured to dynamically determine from the full scan a frequency for at least one of the short scan measuring points.
In one embodiment, in the controller is configured to select a frequency value corresponding to lowest drive current as a frequency for a short scan measuring point. Preferably, said lowest drive current is determined to correspond to a resonant frequency, and a frequency value for the full scan measuring point with lowest drive current is stored for use as a short scan measuring point frequency.
In one embodiment, the parameter is aperture plate drive current.
In one embodiment, the controller is configured to, during a full scan:
In one embodiment, a slope in parameter measurements is analysed to determine said indication in each iteration. In one embodiment, a slope value above a threshold indicates end of dose.
In another aspect, the invention provides a method of operation of a nebulizer comprising a vibrating aperture plate, a mounting, an actuator, and an aperture plate drive circuit having a controller, wherein the method comprise the steps of the controller:
In one embodiment, the short scan has fewer than five, and preferably two measuring points (CPt #1. CPt #2).
In one embodiment, the controller compares measurements with tolerance ranges, and if a measurement falls outside its associated range a full scan is initiated.
In one embodiment, the short scan is performed at regular intervals, preferably sub-second. Preferably, the full scan has in the range of 5 to 300 measuring points, preferably 100 to 300 measuring points.
In one embodiment, the controller dynamically determines from the full scan a frequency for at least one of the short scan measuring points, and selects a frequency value corresponding to lowest drive current as a frequency for a short scan measuring point.
In one embodiment, said lowest drive current is determined to correspond to a resonant frequency, and a frequency value for the full scan measuring point with lowest drive current is stored for use as a short scan measuring point frequency.
In one embodiment, the parameter is aperture plate drive current.
In one embodiment, the controller during a full scan:
In one embodiment, a slope in parameter measurements is analysed to determine said indication in each iteration Preferably, a slope value above a threshold indicates end of dose.
The invention will be more clearly understood from the following description of some embodiments thereof, given by way of example only with reference to the accompanying drawings in which: —
Referring to
A high voltage resonant circuit (stage 4) conditions the drive signal to ensure efficient coupling of power to the nebulizer load 5.
The mechanical arrangement of aperture plate, actuator and mounting may be of the type which is known for example from our prior specification numbers WO2010035252 and US2012111970.
The circuit of
Short Scan
Referring to
If CPt #1 drive current is outside the current tolerance a flag is set for a full scan. If not, the frequency is changed to a second reference frequency. The latter is determined according to a full scan. The drive current value for the CPt #2 frequency is determined. Likewise, if it is outside the tolerance the full scan flag is set. This loop is repeated at regular intervals, multiple times per second.
The short scan is run at intervals in the order of every second or less. It only moves away from the normal operating frequency for less than 1/1000th of a second while it measures the current at this second point of measurement (CPt #2). This ensures that there is no discernible interruption of the nebulization process.
In summary, the purpose of the short scan is to determine if a full scan should be performed. If the drive current is outside of tolerance then the full scan is activated in order to determine the optimum operating frequency and also to detect end of dose. The short scan does not interfere with operation of the nebulizer because it measures at only two frequencies. One of these is the resonant frequency. CPt #2 is a resonant frequency. In this embodiment the output drive stage 2 drives at CPt #1 with a frequency of 128 KHz, which has been found to provide a good performance across a range of liquid viscosities.
In other embodiments it is possible that once the optimum drive frequency is determined it will be used for CPt #1.
Full Scan
Referring to
At each point in the full scan the aperture plate drive current is determined. This provides a plot of drive current vs. frequency as shown in
The next phase of the logic of
As illustrated by the final steps the slope recorded in the first phase of this scan provides an indication of end of dose.
Importantly, this scan can be used to determine the optimum drive frequency, as described above. Importantly, real time determination of the resonant frequencies gives configurable options for changing operation of the nebulizer to the optimum drive frequency. The resonant frequency may be used for either of the short scan measuring points.
This visual interruption in the plume due to the full scan lasts for only 0.3 of a second. This has negligible effect on operation of the device.
The energy requirement of the aperture plate is directly proportional to the impedance offered by the plate during aerosolization. The impedance of the plate is measured by monitoring one or more electrical characteristics such as voltage, current, or phase difference, and in the above embodiment, drive current.
The impedance of the plate to aerosolization is monitored at the initial drive frequency (CPt #1) and the energy requirements can be determined to be within required limits for correct operation of the vibrating mesh nebulizer, at which point the drive may continue to operate at this frequency.
Alternatively, the frequency of operation of the drive circuit can be adjusted to determine the optimum operating point for the piezo-element. This can be the anti-resonance point (CPt #2 frequency), where the minimum energy consumption occurs (or an offset of this).
A higher frequency, beyond the point of anti-resonance, exists where the energy consumption maximizes and this point is termed the point of resonance.
These points can be used in determination of the optimum operating frequency for the creation of desired flow of aerosolized liquid. There are mechanical reasons why it is preferable not to drive at the resonant point, for example it may not result in the desired flow rate of the nebulizer or the desired particle size or may result in excessive mechanical stress on the aperture plate
Referring to
The point of resonance may provide the maximum flow rate, however this frequency may result in undesirable stresses on the mechanical structure. Runtime variation in the resonance point may also result in undesirable fluctuations in flow rate at this resonance point. Equally, the use of the anti-resonance point may not be desirable as the flow rate may not be sufficient at this point. The optimum frequency may be between these two points and the final frequency can be a fixed offset of one or more of these two points.
In
It will be appreciated that the state of aerosolization (wet/dry) can be determined by monitoring the rate of change of plate impedance between the anti-resonance and the resonance points (or an offset thereof). This is implemented by determining the maximum positive rate of change of impedance between the two resonant frequencies. A steep or abrupt rate of change indicates that no liquid is on the plate (DRY). A flat/gentle rate of change indicates the presence of liquid (WET).
Alternatively, a sudden change in the impedance of the plate at the initial frequency and/or the resonant (CPt #2) frequency can used as a quick method to indicate a possible change in aerosolization state (in the short scan). This is what triggers the full scan to actually determine the end of dose.
It will also be appreciated that the short scan provides much useful information for real time control, but does not cause a visible interruption in aerosolization. The short scan is run in advance of a full scan, which can cause a visible interruption in the aerosolization of liquid.
In summary, the software procedure implemented by the controller for determining the status of the nebulizer is as follows:
In some embodiments, the controller may initiate a full scan after a predetermined time (such as a further 5 seconds). The purpose of this additional scan is to record the maximum slope after the device has completed 5 seconds in the new state. When a device changes state, the change in the current/slope profile is almost instantaneous. However, after an additional few seconds the new profile will have changed again slightly, due to changes in the mechanical structure of the plate. to a value that the nebulizer will maintain over a longer period of time. It is important to determine this stable value to ensure that the short scan has details of the correct frequency to monitor. When prompted by the short scan (or at predefined periods e.g. 5 seconds) the purpose of the predefined full scan may be to update the check points for the quick scan, as these two points may drift slightly during normal run mode.
The short scan checks the current consumption at the normal operating frequency and at one other point every interval (every second or less). If a change is found at either of these two frequencies the controller will flag a possible change of state (i.e. the device may have changed from wet to dry or from dry to wet). This change will result in a call of the full scan.
In one embodiment, for the full scan the algorithm calculates a slope/differential of the drive current at each frequency step. As the algorithm steps through the frequencies, it measures the current and then subtracts the current measurement taken 16 frequency steps previously using a rolling shift register.
The invention is not limited to the embodiments described but may be varied in construction and detail.
Number | Date | Country | Kind |
---|---|---|---|
13177909 | Jul 2013 | EP | regional |
This application is a continuation application under 37 CFR § 1.53(b) of U.S. patent application Ser. No. 16/572,298, filed Sep. 16, 2019, which is a continuation of U.S. patent application Ser. No. 15/933,082, filed Mar. 22, 2018, which is a continuation application of U.S. patent application Ser. No. 14/423,046, filed Feb. 20, 2015, which is a National Stage of PCT/EP2014/060723, filed May 23, 2014, which claims priority to European Patent Application No. EP13177909.2, filed Jul. 24, 2013. The contents of each of these are incorporated herein by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
6546927 | Litherland et al. | Apr 2003 | B2 |
9956356 | Grehan et al. | May 2018 | B2 |
10449307 | Grehan et al. | Oct 2019 | B2 |
11065399 | Grehan | Jul 2021 | B2 |
20030150446 | Patel et al. | Aug 2003 | A1 |
20050217666 | Fink et al. | Oct 2005 | A1 |
20060102172 | Feiner et al. | May 2006 | A1 |
20070240712 | Fleming et al. | Oct 2007 | A1 |
20120111970 | Hogan et al. | May 2012 | A1 |
20180256829 | Grehan et al. | Sep 2018 | A1 |
Number | Date | Country |
---|---|---|
1 558 315 | Oct 2005 | EP |
2 047 914 | Apr 2009 | EP |
WO 9309881 | May 1993 | WO |
WO 2004039442 | May 2004 | WO |
WO 2009118717 | Oct 2009 | WO |
WO 2010035251 | Apr 2010 | WO |
WO 2010035252 | Apr 2010 | WO |
WO 2010035252 | Apr 2010 | WO |
WO 2011091002 | Jul 2011 | WO |
Entry |
---|
International Search Report and Written Opinion for International Application No. PCT/EP2014/060723, dated Aug. 26, 2014 (8 pages). |
Number | Date | Country | |
---|---|---|---|
20210308387 A1 | Oct 2021 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16572298 | Sep 2019 | US |
Child | 17350562 | US | |
Parent | 15933082 | Mar 2018 | US |
Child | 16572298 | US | |
Parent | 14423046 | US | |
Child | 15933082 | US |